Biblio

Export 1231 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is D  [Clear All Filters]
2016
S. Martire, Fuso, A., Mosca, L., Forte, E., Correani, V., Fontana, M., Scarpa, S., Maras, B., and d'Erme, M., “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
A. M. Fernandez, Hervas, R., Dominguez-Fraile, M., Garrido, V. Navarro, Gomez-Gutierrez, P., Vega, M., Vitorica, J., Perez, J. J., and Aleman, I. Torres, “Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1471-8, 2016.
H. - J. Kim, Im, H. Kyun, Kim, J., Han, J. - Y., de Leon, M., Deshpande, A., and Moon, W. - J., “Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1101-9, 2016.
H. - J. Kim, Im, H. Kyun, Kim, J., Han, J. - Y., de Leon, M., Deshpande, A., and Moon, W. - J., “Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1101-9, 2016.
Y. Vermeiren, Janssens, J., Aerts, T., Martin, J. - J., Sieben, A., Van Dam, D., and De Deyn, P. P., “Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1079-96, 2016.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., “Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., “Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.”, J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
R. E. Curiel, Crocco, E., Rosado, M., Duara, R., Greig, M. T., Raffo, A., and Loewenstein, D. A., “A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 54, no. 2, pp. 793-9, 2016.
L. De Beaumont, Pelleieux, S., Lamarre-Théroux, L., Dea, D., and Poirier, J., “Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.”, J Alzheimers Dis, vol. 54, no. 3, pp. 913-922, 2016.
L. De Beaumont, Pelleieux, S., Lamarre-Théroux, L., Dea, D., and Poirier, J., “Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.”, J Alzheimers Dis, vol. 54, no. 3, pp. 913-922, 2016.
D. Renard, Gabelle, A., Hirtz, C., Demattei, C., Thouvenot, E., and Lehmann, S., “Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1291-1295, 2016.
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., “Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., “Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., “Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
A. De Vos, Struyfs, H., Jacobs, D., Fransen, E., Klewansky, T., De Roeck, E., Robberecht, C., Van Broeckhoven, C., Duyckaerts, C., Engelborghs, S., and Vanmechelen, E., “The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1523-38, 2016.
A. De Vos, Struyfs, H., Jacobs, D., Fransen, E., Klewansky, T., De Roeck, E., Robberecht, C., Van Broeckhoven, C., Duyckaerts, C., Engelborghs, S., and Vanmechelen, E., “The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1523-38, 2016.
A. De Vos, Struyfs, H., Jacobs, D., Fransen, E., Klewansky, T., De Roeck, E., Robberecht, C., Van Broeckhoven, C., Duyckaerts, C., Engelborghs, S., and Vanmechelen, E., “The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1523-38, 2016.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., “Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., “Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders.”, J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
E. Vallino Costassa, Fiorini, M., Zanusso, G., Peletto, S., Acutis, P., Baioni, E., Maurella, C., Tagliavini, F., Catania, M., Gallo, M., Faro, M. Lo, Chieppa, M. Novella, Meloni, D., D'Angelo, A., Paciello, O., Ghidoni, R., Tonoli, E., Casalone, C., and Corona, C., “Characterization of Amyloid-β Deposits in Bovine Brains.”, J Alzheimers Dis, vol. 51, no. 3, pp. 875-87, 2016.
M. Kleinschmidt, Schoenfeld, R., Göttlich, C., Bittner, D., Metzner, J. Erich, Leplow, B., and Demuth, H. - U., “Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.”, J Alzheimers Dis, vol. 50, no. 1, pp. 111-26, 2016.
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., “Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., “Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
A. Moreira, Diógenes, M. José, de Mendonça, A., Lunet, N., and Barros, H., “Chocolate Consumption is Associated with a Lower Risk of Cognitive Decline.”, J Alzheimers Dis, vol. 53, no. 1, pp. 85-93, 2016.
A. Moreira, Diógenes, M. José, de Mendonça, A., Lunet, N., and Barros, H., “Chocolate Consumption is Associated with a Lower Risk of Cognitive Decline.”, J Alzheimers Dis, vol. 53, no. 1, pp. 85-93, 2016.

Pages